The preparation and evaluation of xanthinyl analogues as inhibitors of monoamine oxidase B / Kevin Robert Zoellner
Monoamine oxidase B (MAO-B) is a drug target for the treatment of neurodegenerative diseases such as Parkinson's disease. For example, the mechanism-based inactivator of MAO-B, (R)-deprenyl, is frequently used in combination with L-dopa as dopamine replacement therapy in Parkinson's diseas...
| Main Author: | |
|---|---|
| Published: |
North-West University
2009
|
| Online Access: | http://hdl.handle.net/10394/1382 |